Chikungunya Vaccine for Travel: Do You Need It in 2026?

Chikungunya has quietly become one of the more active travel health stories of 2026. CDC currently has Level 2 travel health notices — "practice enhanced precautions" — covering outbreak areas across South America, the Indian Ocean, and Asia simultaneously, and for the first time, there's a genuinely new option on the table: a licensed chikungunya vaccine that more travellers are now considering before departure.

Here's what chikungunya actually is, where it's currently active, and how to think about the vaccine question for your own trip.

What chikungunya actually is

Chikungunya is a viral disease spread by the bite of an infected Aedes mosquito — the same mosquito species behind dengue and Zika, which is why all three tend to show up in overlapping regions. The name comes from a Makonde word roughly meaning "to become contorted," a nod to the joint pain that bends sufferers over.

Symptoms typically start 3–7 days after a bite and include sudden fever and often severe joint pain, along with possible headache, muscle pain, joint swelling, or rash. Most people recover within a week, but a meaningful number go on to have joint pain that lingers for months or, in some cases, years. Death is rare, but newborns infected around the time of birth, adults 65 and older, and people with underlying conditions like diabetes or heart disease face a higher risk of severe illness. There's currently no antiviral treatment — care is supportive (rest, fluids, pain relief) — which is exactly why prevention, including vaccination where appropriate, matters more here than for diseases with a treatment fallback.

Where chikungunya is active right now

The outbreak picture shifts often enough that we won't hard-code a list here — but as a sense of current geographic spread, CDC has recently maintained active travel health notices covering locations including Bolivia (Santa Cruz and Cochabamba departments), Mayotte, Réunion, Seychelles, Mauritius, Somalia, Kenya, Madagascar, Sri Lanka, and Guangdong Province in China, with additional activity reported in Costa Rica and Nicaragua. That's genuinely four continents at once, which is unusual even for a disease that has a long history of large, wave-like outbreaks.

Before any trip to a region with a history of chikungunya activity, check the live picture directly:

• CDC Travel Health Notices
• NaTHNaC TravelHealthPro
• WHO Disease Outbreak News

The vaccine: what's actually available

As of 2026, the main chikungunya vaccine available in the US and a growing number of other countries is VIMKUNYA, a virus-like particle vaccine made by Bavarian Nordic. It's licensed for people aged 12 and older, given as a single intramuscular dose, and clinical trial data showed a strong antibody response in the vast majority of recipients within weeks — holding up reasonably well through six months, though longer-term durability data is still being gathered.

A second vaccine, IXCHIQ (a live-attenuated vaccine from Valneva, approved for adults 18+), has also been available, but its safety profile has been under closer scrutiny — regulators paused and then revised its use in older adults after reports of serious cardiac and neurologic adverse events, and its market availability has shifted since. Because the situation around IXCHIQ has continued to evolve, ask your travel clinic directly which vaccine they're offering and why, rather than assuming either one by name.

Neither vaccine is required for entry anywhere. Unlike yellow fever or Saudi Arabia's meningitis rule, no country currently mandates proof of chikungunya vaccination — this is entirely a recommendation based on your personal risk.

Who it's actually recommended for

Chikungunya vaccination isn't suggested for every international trip — it's targeted at genuine exposure risk:

• Recommended: travellers aged 12+ heading to a country or territory with an active chikungunya outbreak
• Worth considering: travellers aged 12+ moving to or spending an extended period (roughly 6 months or more) in a country with elevated chikungunya risk, even without a current active outbreak
• Recommended: laboratory workers with potential occupational exposure to the virus

For a typical two-week holiday to a destination without an active outbreak, this generally isn't necessary — bite prevention remains the main line of defence either way. This is one to raise specifically if your destination appears on the current outbreak list above.

Pregnancy and other precautions

Pregnancy is a precaution for chikungunya vaccination — not an outright contraindication, but a genuine risk-benefit conversation to have with a provider, particularly since chikungunya infection around the time of delivery can be passed to a newborn with serious consequences. Vaccination during pregnancy is generally deferred where possible, unless real exposure risk can't reasonably be avoided. Breastfeeding is not considered a contraindication. See our pregnancy and children's travel vaccines guide for how this fits alongside other travel vaccine decisions during pregnancy.

A history of severe allergic reaction to any vaccine component is a contraindication regardless of age or pregnancy status — as with any vaccine, this is a conversation for your specific medical history, not a generic checklist.

Prevention still matters — vaccinated or not

Because there's no cure and the vaccine's real-world durability is still being studied, standard mosquito bite prevention remains essential even for vaccinated travellers: DEET or picaridin repellent, long sleeves and trousers particularly at dawn and dusk when Aedes mosquitoes are most active, and screened or air-conditioned accommodation. See our mosquito bite prevention guide for the specifics on what actually works, and our dengue guide since the two diseases share a mosquito and often the same outbreak regions.

Getting it sorted

Check current destination-specific risk using the Travel Vaccine Map tool, and use Find a Clinic to book with a travel health provider — since the vaccine landscape here has moved quickly over the past two years, a same-week consultation is your best way to get current, personalised guidance rather than relying on any static list, including this one.

Sources: CDC Chikungunya Travel Notices, CDC Chikungunya Vaccine Information, WHO Chikungunya, ECDC Communicable Disease Threats Reports.